中新藥業(600329.SH)子公司獲得《藥品GMP證書》
格隆匯11月28日丨中新藥業(600329.SH)公佈,近日,天津中新藥業集團股份有限公司全資子公司天津市中藥飲片廠有限公司收到天津市藥品監督管理局頒佈的《藥品GMP證書》,認證範圍:中藥飲片(直接口服飲片);有效期至:2024年11月12日。
天津市中藥飲片廠有限公司(原天津市中藥飲片廠),始建於1958年,現為天津中新藥業集團股份有限公司全資子公司,是天津市歷史最為悠久的中藥飲片生產經營企業。企業始終秉承“取百草精華,擔社會責任,保百姓健康”的企業宗旨,將傳統中藥優勢與現代技術相結合,着力打造“津春”品牌中藥飲片,傳承中藥飲片事業的發展。
企業生產經營場地分為三地:一是在長江道廠區主要包括各行政辦公部門和GSP倉庫;二是在安國市祁州工業城河南大道5號(安國車間),建築面積達5000餘平方米,包括普通中藥飲片、毒性中藥飲片、炒炙煅生產車間、粉碎車間(共用車間);三是在天津市西青區西青道278號(西青車間),建築面積達3000餘平方米,包括普通中藥飲片、直接口服中藥飲片生產車間、包裝車間,以及化驗室。企業主要從事中藥飲片生產經營。企業固定資產原值1083萬元,固定資產淨值584萬元。現有員工134人,其中藥學及相關專業技術人員73人,具有較強的生產經營質量管理和市場營銷能力。
此次認證的直接口服中藥飲片生產車間主要生產三七粉,三七粉的功能與主治:散瘀止血,消腫定痛。用於咯血,吐血,衄血,便血,崩漏,外傷出血,胸腹刺痛,跌撲腫痛。
此次天津市中藥飲片廠有限公司直接口服中藥飲片生產車間獲得《藥品GMP證書》,增加了中新藥業直接口服中藥飲片的品種線,滿足了市場需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.